NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Bloomberg Law 2025, the latest installment of Bloomberg Law’s annual outlook series, features more than 30 articles from our ...

Current legislation before Congress, including the Modernizing and Ensuring PBM Accountability Act (S.2973) and the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 (S.3430), ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

The Federal Trade Commission (FTC) on September 27, 2024 unexpectedly withdrew from a recently established Memorandum of Understanding (MOU) with ...

Former President Donald Trump's reascension to the Oval Office puts Affordable Care Act rules and subsidies in doubt, and raises many questions for the healthcare sector.

The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...